News

Interview with Dr. Anneke Hesseling – Part One

Dr. Anneke Hesseling is the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa. She has South African and US training in Medicine and Epidemiology and is the PI and co-PI on several large research projects relates to the epidemiology, transmission and diagnosis of tuberculosis in children, with special emphasis on the interaction between pediatric TB and HIV and the immunologic diagnosis of TB infection and disease. Dr. Hesseling has a special research interest in the epidemiologic and immunologic interaction between BCG and HIV in children and is the chairperson of the IUATLD BCG Working Group.

An interview with Dr. Hesseling from the 41st Union World Conference on Lung Health in Berlin can be found on the Science Speaks blog here.

More News
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...